DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/gs28p5/head_and_neck) has announced the addition of the "Head And Neck Cancer - Pipeline Review, H1 2015" report to their offering.
This report provides comprehensive information on the therapeutic development for Head And Neck Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Head And Neck Cancer and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Key Topics Covered:
- Introduction
- Head And Neck Cancer Overview
- Therapeutics Development
- Head And Neck Cancer - Therapeutics under Development by Companies
- Head And Neck Cancer - Therapeutics under Investigation by Universities/Institutes
- Head And Neck Cancer - Pipeline Products Glance
- Head And Neck Cancer - Products under Development by Companies
- Head And Neck Cancer - Products under Investigation by Universities/Institutes
- Head And Neck Cancer - Companies Involved in Therapeutics Development
- Head And Neck Cancer - Therapeutics Assessment
- Drug Profiles
- Head And Neck Cancer - Recent Pipeline Updates
- Head And Neck Cancer - Dormant Projects
- Head And Neck Cancer - Discontinued Products
- Head And Neck Cancer - Product Development Milestones
- Appendix
Companies Mentioned
- ArQule, Inc.
- Ascenta Therapeutics, Inc.
- Astellas Pharma Inc.
- AstraZeneca PLC
- AVEO Pharmaceuticals, Inc.
- Gliknik, Inc.
- Glycotope GmbH
- Green Cross Corporation
- ImmunoGen, Inc.
- Immunomedics, Inc.
- Immunovative Therapies, Ltd.
- Merck KGaA.
- Oncobiologics, Inc.
- Oncolys BioPharma Inc.
- Oncolytics Biotech Inc.
- Onconova Therapeutics, Inc.
- OncoSec Medical Inc.
- Oncovir, Inc.
- Piramal Enterprises Limited
- PlantForm Corporation
- PNP Therapeutics, Inc.
- Profectus BioSciences, Inc.
- Sareum Holdings plc
- Selecta Biosciences, Inc.
- Takara Bio Inc.
- Teva Pharmaceutical Industries Limited
- Theravectys S.A.
- Transgene SA
- VasGene Therapeutics, Inc.
- VentiRx Pharmaceuticals, Inc.
For more information visit http://www.researchandmarkets.com/research/gs28p5/head_and_neck
